—HST
— • —
$20.14
P/E
18.28
PEG
0.02
FCF Yield
—
Rev Growth YoY
+757.0% YoY
Gross Margin
9501.0%
Health Score
5/10
D/E Ratio
0.77
Confidence
LOW
Business Snapshot
The ticker provided contains no exchange, sector, industry, or company name data, making a precise business description impossible from the payload alone. Based on available financial metrics, this appears to be a very small company — with a P/E of 18.28x and a Price/Sales of 2.24x — likely operating in a niche market. Without market capitalisation data, the cap tier cannot be formally classified, though the profile suggests micro- or small-cap territory.
Financial Health
Score: 5/10
The financial profile contains several extraordinary-looking figures alongside meaningful gaps. Gross margin is reported at 9,501% and net margin at 1,251%, which are almost certainly the result of accounting distortions, restatements, or base-effect anomalies rather than genuine operating efficiency — a serious transparency concern...
Risk Assessment
- DATA INTEGRITY: Gross margin of 9,501% and net margin of 1,251% are economically implausible figures that strongly suggest accounting distortions, making all profitability conclusions unreliable.
- GROWTH BASE EFFECT: Revenue growth of 757% YoY and earnings growth of 1,140% YoY almost certainly reflect an abnormally depressed prior-year base rather than sustainable organic expansion.
- CASH FLOW OPACITY: Free Cash Flow is unavailable, meaning reported earnings cannot be validated against actual cash generation — a critical blind spot for any fundamental assessment.
- TECHNICAL DETERIORATION: Price is trading below both the 50-day and 200-day moving averages, and a death cross formation is confirmed, indicating sustained downward price momentum.
- IDENTIFICATION RISK: No company name, exchange, sector, or industry is provided, making peer comparison, regulatory context, and risk-category assessment impossible.
---...
**Score: 5/10** The financial profile contains several extraordinary-looking figures alongside meaningful gaps. Gross margin is reported at 9,501% and net margin at 1,251%, which are almost certainly the result of accounting distortions, restatements, or base-effect anomalies rather than genuine operating efficiency — a serious transparency concern. The Debt/Equity ratio of 0.77x is manageable and does not signal immediate balance sheet stress. However, Free Cash Flow is unavailable, making it impossible to assess the quality of reported earnings or the company's ability to self-fund operations. ---
- **DATA INTEGRITY:** Gross margin of 9,501% and net margin of 1,251% are economically implausible figures that strongly suggest accounting distortions, making all profitability conclusions unreliable. - **GROWTH BASE EFFECT:** Revenue growth of 757% YoY and earnings growth of 1,140% YoY almost certainly reflect an abnormally depressed prior-year base rather than sustainable organic expansion. - **CASH FLOW OPACITY:** Free Cash Flow is unavailable, meaning reported earnings cannot be validated against actual cash generation — a critical blind spot for any fundamental assessment. - **TECHNICAL DETERIORATION:** Price is trading below both the 50-day and 200-day moving averages, and a death cross formation is confirmed, indicating sustained downward price momentum. - **IDENTIFICATION RISK:** No company name, exchange, sector, or industry is provided, making peer comparison, regulatory context, and risk-category assessment impossible. ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives